Marie A. Vodicka
Guide to Recent Biosimilar Activity by FDA and in the Supreme Court
Biosimilars Law Blog ·
FDA Denies Three Petitions on Biosimilar Labeling: Refers Petitioners to Guidance Process
Biosimilars Law Blog ·
FDA Announces Policy for Unique Nonproprietary Names for Biologics and Biosimilars
Biosimilars Law Blog ·